To enhance our insights into the prognostic validity of the five-gene signature, we examined the expression of ATP6AP1, SLC7A5, EPDR1, SDC1, and PIGR in 13 paired BC samples, comparing them with their adjacent non-tumor tissues through RT-PCR. The gene discussed is ATP6AP1; the disease is breast cancer.